Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- Fianlimab [Fixed ]Phase 22 trials
Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
- FL115Phase 22 trials
Suzhou Forlong Biotechnology Co., Ltd · Advanced Solid Tumors, Non-muscle Invasive Bladder Cancer (NMIBC)
- FMC-376Phase 22 trials
Frontier Medicines Corporation · Advanced Solid Tumors With KRAS G12C Mutations, Solid Tumor, Adult, Unresectable Solid Tumor
- FWD1802Phase 22 trials
Forward Pharmaceuticals Co., Ltd. · Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage IV
- GI-102Phase 22 trials
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Soft Tissue Sarcoma (STS)
- GKL-006iNKT cellsPhase 22 trials
Beijing Gene Key Life Technology Co., Ltd · Advanced Pancreatic Cancer, Ductal Adenocarcinoma of Pancreas, Hepatocellular Carcinoma (HCC)
- GT201Phase 22 trials
Grit Biotechnology · Advanced Solid Tumors, Advanced Solid Tumors Cancer
- GW5282Phase 22 trials
Dizal Pharmaceuticals · T-cell Lymphomas, Advanced Solid Tumors
- HDM2017Phase 22 trials
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · CRC, Colorectal Cancer, Colorectal Cancer Metastatic
- HH2853Phase 22 trials
Haihe Biopharma Co., Ltd. · Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL), FL Lymphoma, Epithelioid Sarcoma
- HRS-1167Phase 22 trials
Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer
- HRS-1358Phase 22 trials
Shandong Suncadia Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer, Advanced Solid Tumors
- HRS-5041Phase 22 trials
Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer
- HRS-6208Phase 22 trials
Shandong Suncadia Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer of Adults, Prostate Cancer
- HRS-9813Phase 22 trials
Jiangsu HengRui Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer, Advanced Solid Tumors, IPF and PPF
- IBB0979Phase 22 trials
SUNHO(China)BioPharmaceutical CO., Ltd. · Small Cell Lung Cancer, Advanced Malignant Tumors
- ICP-723Phase 22 trials
Beijing InnoCare Pharma Tech Co., Ltd. · Advanced Solid Tumors Harboring NTRK Fusion, Primary Central Nervous System Tumors Harboring NTRK Fusion, Solid Tumors
- IDP-121Phase 22 trials
IDP Discovery Pharma S.L. · Small Cell Lung Cancer ( SCLC ), Multiple Myeloma (MM), Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- IMGN632Phase 22 trials
AbbVie · Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm, Acute Myeloid Leukemia
- ImzokitugBMS-986340Phase 22 trials
Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer
- INO-5401Phase 22 trials
Inovio Pharmaceuticals · Glioblastoma, Urothelial Carcinoma
- Intracerebroventricular of MT027 UCAR-T Cell targeting B7H3Phase 22 trials
T-MAXIMUM Pharmaceutical Inc · Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Brain Metastases From Solid Tumors
- IPG7236Phase 22 trials
Nanjing Immunophage Biotech Co., Ltd · Advanced Solid Tumor, Safety Issues, Tolerability
- itacitinibINCB039110Phase 22 trials
Incyte · B-Cell Malignancies, Lung Cancer
- JAB-8263Phase 22 trials
Jacobio Pharmaceuticals Co., Ltd. · Rheumatoid Arthritis (RA), NSCLC, SCLC
- JMT108Phase 22 trials
Shanghai JMT-Bio Inc. · Unresectable Locally Advanced or Metastatic Melanoma, Unresectable Locally Advanced or Metastatic Urinary Tract Tumors, Advanced Malignant Tumors
- JS207Phase 22 trials
Mabwell (Shanghai) Bioscience Co., Ltd. · Solid Tumor, Advanced Solid Tumor
- KB707Phase 22 trials
Krystal Biotech, Inc. · Cancer, Melanoma Stage III, Melanoma Stage IV
- KCBT-1083BEBT-109Phase 22 trials
BeBetter Med Inc · Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation
- KN046Recombinant Humanized PD-L1, CTLA-4 Bispecific Single Domain Antibody Fc Fusion ProteinPhase 22 trials
InxMed (Shanghai) Co., Ltd. · Pancreatic Cancer, Advanced Non-small Cell Lung Cancer
- LM-168Phase 22 trials
LaNova Medicines Limited · Advanced Solid Tumor, Advanced Solid Tumours
- LM-24C5Phase 22 trials
LaNova Medicines Limited · Advanced Solid Tumor, Advanced Solid Tumor Cancer
- LM-364Phase 22 trials
LaNova Medicines Limited · Advanced Solid Tumor Cancer, Malignant Tumors
- LM103 TILsPhase 22 trials
Suzhou BlueHorse Therapeutics Co., Ltd. · Advanced Melanoma, Non-Small Cell Lung Cancer
- LorigerlimabMGD019Phase 22 trials
MacroGenics · Platinum-resistant Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma
- LS301-ITPhase 22 trials
Integro Theranostics · Non Small Cell Lung Cancer (NSCLC), Breast Cancer, DCIS
- LY188011Phase 22 trials
Eli Lilly · Neoplasms, Child, Adolescent
- M1774TuvusertibPhase 22 trials
EMD Serono Research & Development Institute, Inc. · Non-Small Cell Lung Cancer, Ovarian Cancer
- Monoclonal antibodyPhase 22 trials
Immunocore Ltd · Cancer, HLA-A*02:01-positive, Refractory Cancer
- MRG006APhase 22 trials
Lepu Biopharma Co., Ltd. · Advanced Solid Tumors, Hepatocellular Carcinoma
- MRT-2359Phase 22 trials
Monte Rosa Therapeutics, Inc · Prostate Cancer, NSCLC, SCLC
- MT-125Phase 22 trials
Myosin Therapeutics Inc. · Glioblastoma (GBM), Glioblastoma
- NBM-BMXPhase 22 trials
Novelwise Pharmaceutical Corporation · Malignant Neoplasm of Brain, Malignant Neoplasm
- NelistotugGSK6097608Phase 22 trials
GSK · Lung Cancer, Non-Small Cell, Neoplasms, Head and Neck
- NelmastobartPhase 22 trials
STCube, Inc. · Metastatic Colorectal Cancer (CRC), Recurrent Colorectal Cancer, Non Small Cell Lung Cancer
- NEO100Perillyl alcoholPhase 22 trials
Neonc Technologies, Inc. · Glioblastoma Multiforme, Residual, Progressive or Recurrent Grade II or III Meningioma
- NLM-001Phase 22 trials
Nelum Corp · Untreated, Advanced Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma
- ODM-212Phase 22 trials
Orion Corporation, Orion Pharma · Solid Tumours, Mesothelioma, Pancreatic Cancer
- Olaptesed pegolNOX-A12Phase 22 trials
TME Pharma AG · Metastatic Pancreatic Cancer, Glioblastoma
- ONC206JZP3507Phase 22 trials
Jazz Pharmaceuticals · Meningioma, Advanced Pheochromocytoma and Paraganglioma, PCPG
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.